Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China
· Delayed Price · Currency is CNY 15.29
+0.02 (0.13%)
May 14, 2025, 2:45 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Traditional Chinese Medicine | 6.02B |
Log In |
Log In |
Log In |
Log In |
| Traditional Chinese Medicine Growth | 0.88% |
Log In |
Log In |
Log In |
Log In |
| Chemical Preparations | 1.31B |
Log In |
Log In |
Log In |
Log In |
| Chemical Preparations Growth | 8.62% |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical Business | 894.55M |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical Business Growth | -26.39% |
Log In |
Log In |
Log In |
Log In |
| Biological Drugs | 191.53M |
Log In |
Log In |
Log In |
Log In |
| Biological Drugs Growth | 1.06% |
Log In |
Log In |
Log In |
Log In |
| Chemical Raw Materials | 51.70M |
Log In |
Log In |
Log In |
Log In |
| Chemical Raw Materials Growth | -9.51% |
Log In |
Log In |
Log In |
Log In |
| Other Business | 29.81M |
Log In |
Log In |
Log In |
Log In |
| Other Business Growth | -20.95% |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical Industry | - |
Log In |
Log In |
Log In |
Log In |
| Pharmaceutical Industry Growth | - |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| China | 8.46B |
Log In |
Log In |
Log In |
Log In |
| China Growth | -1.98% |
Log In |
Log In |
Log In |
Log In |
| Overseas | 20.79M |
Log In |
Log In |
Log In |
Log In |
| Overseas Growth | -11.43% |
Log In |
Log In |
Log In |
Log In |